Evidence map›Paper›PMID 33020162›Full record

ArticleAntimicrobial agents and chemotherapy2020

Tolerance of Gambian Plasmodium falciparum to Dihydroartemisinin and Lumefantrine Detected by

Haddijatou Mbye, Fatoumata Bojang, Aminata Seedy Jawara, Bekai Njie, Nuredin Ibrahim Mohammed, Joseph Okebe, Umberto D'Alessandro, Alfred Amambua-Ngwa

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Plasmodium falciparum isolates: ex vivo drug response.The Journal of antimicrobial chemotherapy · 2025
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Haddijatou MbyeWest African Centre for Cell Biology of Infectious Pathogens, Department of Biochemistry, Cell and Molecular Biology, University of Ghana, Legon, Ghana.
Fatoumata BojangMRC Unit The Gambia at London School of Hygiene and Tropical Medicine, Fajara, The Gambia.
Aminata Seedy JawaraMRC Unit The Gambia at London School of Hygiene and Tropical Medicine, Fajara, The Gambia.
Bekai NjieMRC Unit The Gambia at London School of Hygiene and Tropical Medicine, Fajara, The Gambia.
Nuredin Ibrahim MohammedMRC Unit The Gambia at London School of Hygiene and Tropical Medicine, Fajara, The Gambia.
Joseph OkebeDepartment of International Public Health, Liverpool School of Tropical Medicine, United Kingdom.
Umberto D'AlessandroMRC Unit The Gambia at London School of Hygiene and Tropical Medicine, Fajara, The Gambia.
Alfred Amambua-NgwaMRC Unit The Gambia at London School of Hygiene and Tropical Medicine, Fajara, The Gambia angwa@mrc.gm.ORCID 0000-0003-4478-3601
MRC Unit the Gambia · GMLondon School of Hygiene & Tropical Medicine · GBLiverpool School of Tropical Medicine · GBUniversity of Ghana · GH

Funding

Medical Research Council MC_EX_MR/K02440X/1Medical Research Council MC_UP_A900_1119Medical Research Council MR/R010161/1Wellcome TrustWellcome Trust 107755/Z/15/Z
6 · The paper itself

Abstract

Monitoring of

Indexed as

AntimalarialsArtemisininsMalaria, FalciparumParasitesAfricaAnimalsDrug ResistanceGambiaLumefantrinePlasmodium falciparumProtozoan ProteinsSurvival RateAntimalarialsArtemisininsartenimolLumefantrineProtozoan Proteinsantimalarial agentsartemisinin combination therapiesdrug resistancedrug toleranceex vivoex vivo survival ratesflow cytometrygenotypesPlasmodium falciparum

Identifiers

PMID33020162
PMCPMC7927851
OpenAlexW3089385289

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.